Updated: Jul 4, 2019
The OECD report ‘Stemming the Superbug Tide: Just a Few Dollars More’ describes the long-term public health and economics consequences of the rise in AMR and identifies effective solutions to tackle this top public health priority. Using the latest statistical techniques, OECD projected resistance rates for major bug-drug combinations in over 50 countries and calculated that resistance to second and third-line antibiotics in OECD and G20 countries may be 70% higher in 2030, compared to rates in 2005, if no effective action is put in place. OECD further assessed the effectiveness and cost-effectiveness of public policies to contain AMR. The findings presented in this publication identify ‘best buys’ – i.e. affordable, feasible and highly cost-effective interventions – for AMR in the human health sector. The country-specific results represent the most comprehensive and detailed assessment of AMR health and economic effects that have yet been undertaken and provide evidence to guide countries in their policy-making process.
For the first time, empirical evidence is presented showing that AMR can be reduced significantly and its burden on population health and healthcare expenditure drastically reduced. Further information on the report can be found at: oe.cd/amr-2018.
Michele Cecchini, PhD, Senior Economist, Health Division, OECD, Paris
Experience: Leads the work on Public Health. Michele holds a position of Adjunct Professor in applied health economics at the School of Public Health of the University of Siena (Italy). He has also served as a temporary advisor to government and international agencies, including WHO, IARC, EC and the World Bank.
Education: master’s degree in Health Policy, Planning and Financing from the London School of Economics and the London School of Hygiene and Tropical Medicine and a PhD from Imperial College London.
Driss Ait Ouakrim, PhD, Policy Analyst, Health Division, OECD, Paris
Experience: Epidemiologist and Health Policy Analyst at the OECD. Before joining the OECD, Driss held research and teaching positions at the University of Melbourne Centre for Epidemiology and Biostatistics.
Education: PhD in epidemiology from the University of Melbourne and MPH from the University Claude Bernard Lyon 1.
Tiago Cravo Oliveira Hashiguchi, Policy Analyst, Health Division, OECD, Paris
Experience: Uses modelling and simulation to inform sound policies on such topics as antimicrobial resistance and social protection for long-term care. Before joining the OECD, Tiago held research positions in London at Imperial Business Analytics with KPMG, and in Seattle at the Institute for Health Metrics and Evaluation.
Education: MSc in Biomedical Engineering from the Technical University of Lisbon and PhD in Health Management from Imperial College London